荷兰妊娠期潜在有害药物使用趋势研究
结果显示73%妊娠暴露于任何药物、34%暴露于潜在有害药物,总体用药呈下降趋势,但潜在有害药物暴露比例未见明显变化。
要点
- 34%的妊娠暴露于潜在有害药物,孕前达43%、产后达45%。
- 任何药物暴露从1999年84%降至2017年68%,但潜在有害药物比例无明显变化。
- 需提高医务人员与育龄女性对妊娠期用药潜在风险的重视。
核心结论
- 近二十年荷兰妊娠期潜在有害药物使用比例较高,约三分之一妊娠存在暴露,且随时间无明显改善。
主要发现
- 潜在有害药物暴露率孕前为43%、孕早期24%、孕中期19%、孕晚期16%、产后45%。
- 任何药物暴露从1999年84%降至2017年68%。
- 潜在有害药物暴露比例随时间未见明显变化。
临床怎么用
- 提示临床药师应关注育龄期及妊娠女性的用药风险评估与用药咨询。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Recent population-based data on drug utilization around pregnancy are lacking. This study aims to examine the prevalence of drug exposure in the Netherlands during the preconception, pregnancy and postpartum periods, with special emphasis on trends of potentially harmful medication over the years. METHODS: A population-based study was conducted using records from the PHARMO Perinatal Research Network. From 1999 to 2017, the proportion of pregnancies during which women used any medication or potentially harmful medication was assessed, overall and stratified by timing of exposure relative to pregnancy and by the year of delivery. RESULTS: Overall, 357 226 (73%) and 166 484 (34%) of 487 122 selected pregnancies were exposed to any and potentially harmful medication, respectively. Among these 487 122 pregnancies, preconception prevalence for use of potentially harmful medication was 43%, 24% during the first trimester, 19% during the second, 16% during the third, and 45% postpartum. A declining trend was observed for exposure to any medication, from 84% in 1999 to 68% in 2017. No clear changes were observed over time for the proportion of pregnancies exposed to potentially harmful medication. CONCLUSIONS: Our study shows that the use of potentially harmful medication was high over the last two decades. Although there was a declining trend over the years in overall medication use, during a steady one-third of pregnancies, women used potentially harmful medication. Our findings highlight the need for an increased sense of urgency among both healthcare providers and women of reproductive age regarding potential risks associated with pharmacological treatment during pregnancy.
引用
- Houben E, Te Winkel B, Steegers EAP, et al. Dutch trends in the use of potentially harmful medication during pregnancy. Br J Clin Pharmacol. 2020. PMID: 32374086. doi:10.1111/bcp.14341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。